The Harron Lung Center includes a range of research programs and collaborates with a variety of centers and institute at the University of Pennsylvania. Several important advancements that have become standard of care originated at Penn, such as the single-breath diffusing capacity and body plethysmography.
Research programs at the Paul F. Harron Jr. Lung Center include:
This research program focuses on the pathogenesis and treatment of acute lung injury.
The Asthma and Airway Biology group's research focuses on asthma, chronic obstructive pulmonary disorder (COPD), cystic fibrosis, lymphangioleiomyomatosis and other airways diseases.
This research focuses on environmental exposures and the lung within the context of a genetic predisposition for the induction and progression of airway or lung diseases.
Ronald Collman, MD is investigating how basic mechanisms in HIV-1 biology determine AIDS pathogenesis.
This research focuses on autoimmune, allergic, immunodeficiency disorders and molecular epidemiology of drug allergy
Learn some of the interests of the pulmonary hypertension research team at Penn.
The Surfactant Biology Research Program, which studies the role of surfactant in the lung that includes both biochemical functions of surfactant proteins and the role of surfactant in immunity.
Thoracic oncology conducts cutting-edge diagnostic and therapeutic research related to lung cancer and malignant mesothelioma.
Our surgeons and teams perform lung transplants for patients with advanced lung diseases. Here, we feature our researchers and their current research projects.
Congratulations to the 184 Penn physicians listed below who were included in Philadelphia Magazine's Top Doctors 2016.
Penn Medicine is one of the world’s leading academic medical centers.
A clinical trial is a research study involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions.